BSE:530991

Stock Analysis Report

NOT FOR DISTRIBUTION
Header cover image

Executive Summary

Roopa Industries Limited manufactures, markets, and sells nutraceuticals, bulk drugs, and fine chemicals in India.


Snowflake Analysis

Imperfect balance sheet with questionable track record.

Share Price & News

How has Roopa Industries's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: 530991's share price has been volatile over the past 3 months.


Market Performance


7 Day Return

14.2%

530991

2.9%

IN Chemicals

6.4%

IN Market


1 Year Return

-18.3%

530991

1.5%

IN Chemicals

-14.8%

IN Market

Return vs Industry: 530991 underperformed the Indian Chemicals industry which returned 1.2% over the past year.

Return vs Market: 530991 underperformed the Indian Market which returned -14.8% over the past year.


Shareholder returns

530991IndustryMarket
7 Day14.2%2.9%6.4%
30 Day-16.8%7.7%10.6%
90 Day16.0%-6.5%-7.1%
1 Year-18.3%-18.3%5.8%1.5%-13.1%-14.8%
3 Year-33.2%-33.2%22.4%15.1%-4.1%-9.2%
5 Year60.5%60.5%113.2%95.1%23.2%11.7%

Price Volatility Vs. Market

How volatile is Roopa Industries's share price compared to the market and industry in the last 5 years?


Simply Wall St News

No news available

Valuation

Is Roopa Industries undervalued compared to its fair value and its price relative to the market?

11.26x

Price to Earnings (PE) ratio


Share Price vs. Fair Value

Below Fair Value: Insufficient data to calculate 530991's fair value to establish if it is undervalued.

Significantly Below Fair Value: Insufficient data to calculate 530991's fair value to establish if it is undervalued.


Price To Earnings Ratio

PE vs Industry: 530991 is poor value based on its PE Ratio (11.3x) compared to the Chemicals industry average (9.8x).

PE vs Market: 530991 is poor value based on its PE Ratio (11.3x) compared to the Indian market (10.6x).


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate 530991's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: 530991 is good value based on its PB Ratio (0.7x) compared to the IN Chemicals industry average (1x).


Next Steps

Future Growth

How is Roopa Industries forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

13.5%

Forecasted Materials industry annual growth in earnings


In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Roopa Industries has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Next Steps

Past Performance

How has Roopa Industries performed over the past 5 years?

37.1%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: 530991 has high quality earnings.

Growing Profit Margin: 530991's current net profit margins (1.9%) are lower than last year (2.5%).


Past Earnings Growth Analysis

Earnings Trend: 530991 has become profitable over the past 5 years, growing earnings by 37.1% per year.

Accelerating Growth: 530991's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: 530991 had negative earnings growth (-7.9%) over the past year, making it difficult to compare to the Chemicals industry average (11.6%).


Return on Equity

High ROE: 530991's Return on Equity (6%) is considered low.


Next Steps

Financial Health

How is Roopa Industries's financial position?


Financial Position Analysis

Short Term Liabilities: 530991's short term assets (₹256.4M) exceed its short term liabilities (₹163.6M).

Long Term Liabilities: 530991's short term assets (₹256.4M) exceed its long term liabilities (₹95.2M).


Debt to Equity History and Analysis

Debt Level: 530991's debt to equity ratio (119.3%) is considered high.

Reducing Debt: 530991's debt to equity ratio has increased from 107% to 119.3% over the past 5 years.

Debt Coverage: 530991's debt is not well covered by operating cash flow (11.1%).

Interest Coverage: 530991's interest payments on its debt are not well covered by EBIT (2.2x coverage).


Balance Sheet


Next Steps

Dividend

What is Roopa Industries's current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

Notable Dividend: Unable to evaluate 530991's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate 530991's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if 530991's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if 530991's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of 530991's dividend in 3 years as they are not forecast to pay a notable one for the Indian market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

1.7yrs

Average management tenure


CEO

Tumbalam Raghavendra (65yo)

1.67yrs

Tenure

₹3,000,000

Compensation

Sri Tumbalam G. Raghavendra serves as Managing Director and Executive Chairman of Roopa Industries Ltd. and has been its Executive Director since February 03, 1997. 


CEO Compensation Analysis

Compensation vs Market: Tumbalam's total compensation ($USD39.70K) is about average for companies of similar size in the Indian market ($USD49.97K).

Compensation vs Earnings: Tumbalam's compensation has been consistent with company performance over the past year.


Leadership Team

NamePositionTenureCompensationOwnership
Tumbalam Raghavendra
Executive Chairman & MD1.67yrs₹3.00m10.99% 7.9m
S. Prasad
Chief Financial Officer3.5yrs₹615.00kno data
Vaduguri Sarma
Whole Time Director20.67yrs₹1.20mno data
Siram Lakshmi Prathyusha
Company Secretary & Compliance Officer0.58yrno datano data

1.7yrs

Average Tenure

Experienced Management: 530991's management team is not considered experienced ( 1.7 years average tenure), which suggests a new team.


Board Members

NamePositionTenureCompensationOwnership
Tumbalam Raghavendra
Executive Chairman & MD1.67yrs₹3.00m10.99% 7.9m
Vaduguri Sarma
Whole Time Director20.67yrs₹1.20mno data
O. Rao
Independent Director4.58yrsno datano data
Annadanam Murthy
Independent Director4.58yrsno datano data
S. Karunasree
Independent Woman Director2.83yrsno datano data

4.6yrs

Average Tenure

63yo

Average Age

Experienced Board: 530991's board of directors are considered experienced (4.6 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

Roopa Industries Limited's company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Roopa Industries Limited
  • Ticker: 530991
  • Exchange: BSE
  • Founded: 1985
  • Industry: Specialty Chemicals
  • Sector: Materials
  • Market Cap: ₹71.970m
  • Shares outstanding: 7.87m
  • Website: https://www.roopaindustries.com

Number of Employees


Location

  • Roopa Industries Limited
  • 6-2-1012, TGV Mansion
  • 3rd Floor
  • Hyderabad
  • Andhra Pradesh
  • 500004
  • India

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
530991BSE (Mumbai Stock Exchange)YesEquity SharesININRMay 2005

Biography

Roopa Industries Limited manufactures, markets, and sells nutraceuticals, bulk drugs, and fine chemicals in India. The company offers glucosamine, a nutraceutical/nutritional supplement that is used for the treatment of arthritis; and triphenyl phosphine, which have applications in antibiotics, statins, specialty resins/paints, fire retardants, phosphonium salts, phase transfer catalysts, agriculture related products, etc., as well as in organic synthesis. It also provides bromine and bromine compounds, including meta bromo anisole, tetra butyl ammonium bromide, 1-bromo-3-chloropropane, 1-acetoxy ethyl bromide, etc., which are used in chemical and pharmaceutical industries; sildenafil citrate; and losartan potassium. The company also offers its products in the United States, Japan, and the European Union. Roopa Industries Limited was incorporated in 1985 and is based in Hyderabad, India. 


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2020/06/06 12:34
End of Day Share Price2020/06/05 00:00
Earnings2019/12/31
Annual Earnings2019/03/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.